Sponsored research agreement between Harvard and Roche resulted in the Kahne Lab’s discovery of the mechanism of action for Roche’s compound, paving the way for the development of new antibiotics.

Startup out of SEAS has taken a big step towards turning the lab research into a viable commercial product.

Harvard University and Ono Pharmaceutical Co. (ONO) have launched a strategic alliance today to advance research across a broad range of therapeutic areas.

In race against extinction, new agreement supports Harvard’s work to analyze and digitize its medicinal plant collections